T Cell Function in Chronic Idiopathic Urticaria

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2012 by Meir Medical Center
Sponsor:
Information provided by (Responsible Party):
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01425593
First received: August 28, 2011
Last updated: November 4, 2012
Last verified: November 2012
  Purpose

Chronic idiopathic urticaria (CIU) is a common form of chronic urticaria in which the cause is not detected after intensive clinical and laboratory investigation.In view of the current data, it was suggested that at least part of the patients with CIU have an autoimmune process.This study is designed to investigate the mechanisms involved in the regulation and activation of the immune cells in patients with CIU and corelate them with disease activity


Condition
Chronic Urticaria

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: T Cell Function in Chronic Idiopathic Urticaria

Resource links provided by NLM:


Further study details as provided by Meir Medical Center:

Biospecimen Retention:   Samples Without DNA

venous blood sample


Estimated Enrollment: 40
Study Start Date: March 2009
Estimated Study Completion Date: December 2012
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

patients with chronic urticaria

Criteria

Inclusion Criteria:

  • age above 18
  • chronic urticaria

Exclusion Criteria:

  • age below 18
  • pregnancy
  • other severe chronic diseases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01425593

Locations
Israel
Meir Medical Center Recruiting
Kfar Saba, Israel
Contact: Ronit Cohen Konfino, MD    972-9-7472811    ronitco@clalit.org.il   
Principal Investigator: Ronit Cohen Konfino, MD         
Sponsors and Collaborators
Meir Medical Center
  More Information

No publications provided

Responsible Party: Meir Medical Center
ClinicalTrials.gov Identifier: NCT01425593     History of Changes
Other Study ID Numbers: 0118-08-mmc, confino2009
Study First Received: August 28, 2011
Last Updated: November 4, 2012
Health Authority: Israel: Ethics Commission
Israel: Ministry of Health

Additional relevant MeSH terms:
Urticaria
Skin Diseases, Vascular
Skin Diseases
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on August 26, 2014